This guideline complements the National Institute of Communicable Diseases (NICD) guidelines published as “Clinical Management of Suspected Or Confirmed Covid-19 Disease”, which are updated regularly.  It incorporates guidance on COVID-19 from the WHO, professional bodies and current literature on how patients are managed elsewhere.   Although many drugs are under investigation, current therapeutic strategies to manage confirmed infection are  largely supportive. While significant efforts have been made to deal with the effects of COVID-19 and to prevent a health systems collapse, the provision of essential routine maternal, infant and child health services for women and children needs to be continued and prioritised, including effective and timely emergency services so as not to allow deterioration in the maternal, neonatal and child mortality rates.